L1 Capital International Pty Ltd Acquires 59,188 Shares of HCA Healthcare, Inc. $HCA

L1 Capital International Pty Ltd lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 180.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 91,987 shares of the company’s stock after buying an additional 59,188 shares during the quarter. HCA Healthcare comprises 2.2% of L1 Capital International Pty Ltd’s portfolio, making the stock its 18th biggest holding. L1 Capital International Pty Ltd’s holdings in HCA Healthcare were worth $42,945,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in HCA. Norges Bank bought a new position in HCA Healthcare during the fourth quarter valued at approximately $1,262,513,000. Life Cycle Investment Partners Ltd bought a new position in HCA Healthcare during the fourth quarter valued at approximately $374,037,000. Viking Global Investors LP boosted its stake in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in HCA Healthcare by 4,545.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after buying an additional 649,058 shares during the last quarter. Finally, Danske Bank A S bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $115,530,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Up 2.3%

HCA opened at $387.25 on Friday. The company has a market capitalization of $85.91 billion, a P/E ratio of 13.32, a PEG ratio of 1.20 and a beta of 1.12. The stock’s fifty day moving average is $429.60 and its two-hundred day moving average is $473.48. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s revenue was up 4.3% compared to the same quarter last year. During the same period last year, the business posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Wall Street Analysts Forecast Growth

HCA has been the subject of several analyst reports. Argus lowered their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $525.00 price objective on shares of HCA Healthcare in a research note on Friday, April 24th. Mizuho increased their price target on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. UBS Group increased their price target on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a report on Monday, February 23rd. Finally, Oppenheimer reduced their price target on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $506.14.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.